STAAR will host a conference call and webcast on Wednesday, February 28 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress.
| |
| [14-February-2018] |
| MONROVIA, Calif., Feb. 14, 2018 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the fourth quarter and fiscal year ended December 29, 2017 on Wednesday, February 28, 2018 after the market close. STAAR will host a conference call and webcast on Wednesday, February 28 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and operational progress. To access the conference call (Conference ID 6684729), please dial 855-765-5684 for domestic participants and 262-912-6252 for international participants. The live webcast can be accessed from the investor relations section of the STAAR website at www.staar.com. A taped replay of the conference call (Conference ID 6684729) will be available beginning approximately one hour after the call’s conclusion for seven days. This replay can be accessed by dialing 855-859-2056 for domestic callers and 404-537-3406 for international callers. An archived webcast will also be available at www.staar.com. About STAAR Surgical STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL”. More than 750,000 Visian ICLs have been implanted to date. To learn more about the ICL go to: www.discovericl.com. STAAR has approximately 340 full-time equivalent employees and markets lenses in over 75 countries. Headquartered in Monrovia, CA, the company operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA. For more information, please visit the Company’s website at www.staar.com. CONTACT: Investors & Media EVC Group Brian Moore, 310-579-6199 Doug Sherk, 415-652-9100
View original content:http://www.prnewswire.com/news-releases/staar-surgical-to-report-fourth-quarter-results-on-february-28-2018-300598327.html SOURCE STAAR Surgical Company | ||
Company Codes: NASDAQ-NMS:STAA |
